A detailed history of Pnc Financial Services Group, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,607 shares of PRCT stock, worth $340,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,607
Previous 1,199 200.83%
Holding current value
$340,681
Previous $73,000 294.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$56.31 - $84.99 $135,594 - $204,655
2,408 Added 200.83%
3,607 $288,000
Q2 2024

Aug 09, 2024

BUY
$45.73 - $69.19 $53,732 - $81,298
1,175 Added 4895.83%
1,199 $73,000
Q1 2024

May 10, 2024

BUY
$40.38 - $50.75 $969 - $1,218
24 New
24 $1,000
Q3 2023

Nov 13, 2023

BUY
$30.02 - $38.81 $1,020 - $1,319
34 New
34 $1,000
Q2 2022

Aug 12, 2022

BUY
$29.23 - $44.45 $771,613 - $1.17 Million
26,398 New
26,398 $862,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.21B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.